Farmakoekonomické hodnocení cetuximabu a panitumumabu v 1. linii léčby mCRC v reálné klinické praxi ČR
| Title in English | The Pharmacoeconomic Analysis of Cetuximab and Panitumumab in the 1st Line Treatment of mCRC in Real Clinical Practice in the Czech Republic. |
|---|---|
| Authors | |
| Year of publication | 2019 |
| Type | Article in Periodical |
| Magazine / Source | Klinická onkologie |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.linkos.cz/english-summary/klinicka-onkologie-journal/2019-08-15-4-en/farmakoekonomicke-hodnoceni-cetuximabu-a-panitumumabu-v-1-linii-lecby-mcrc-v-rea-1/ |
| Doi | http://dx.doi.org/10.14735/amko2019288 |
| Keywords | cetuximab; panitumumab; colorectal carcinoma; cost analysis |
| Description | Cost and effectiveness analysis of EGFR inhibitors cetuximab or panitumumab in the first line treatment of metastatic colorectal cancer in the Czech Republic |
| Related projects: |